glp-1 compounding fda is short-sighted on GLP-1s FDA Scrutiny of GLP-1 Compounding

However, older adults, those on certain medications or with gastrointestinal issues, and people who follow a plant-based diet may be more at risk of deficiency

The results of this study revealed that DHS (25 M) pretreatment significantly increased GPx activity by 2.5-fold, followed by faster DNA repair and inhibition of G2/M arrest in the irradiated (4 Gy) cells

Treatment starts at 0.25 mg weekly for four weeks to improve tolerability, then typically increases to 0.5 mg, with further escalation to 1 mg or 2 mg if needed

Pentose phosphate pathway (PPP) activation Increased glycolytic flux diverts glucose-6-phosphate into the PPP, which generates NADPH